HALCION

Main information

  • Trade name:
  • HALCION 0.25 mg tablet
  • Dosage:
  • 0.25 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • HALCION 0.25 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Triazolam
  • Product summary:
  • Suitability for use in older adult patients Triazolamum Avoid using in older persons. Sedative. A short-acting. Significant adverse effects include drug addiction, rebound insomnia, amnesia, cognitive disorder and risk for falls and traffic accidents. Paradoxically, may increase anxiety, restlessness and aggression. Take several interactions into account. Avoid consuming grapefruit juice during treatment.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8515
  • Authorization date:
  • 09-01-2009
  • Last update:
  • 21-02-2018